Class information for:
Level 1: BETA D GALACTOSIDASE//NONCOMPETITIVE IMMUNOASSAY//GELATIN PARTICLE AGGLUTINATION

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
24364 314 21.2 67%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
607 3       BACULOVIRUS//NUCLEOPOLYHEDROVIRUS//CYTOTECHNOLOGY 14212
2591 2             HETEROPHILIC ANTIBODIES//HETEROPHILE ANTIBODIES//JOURNAL OF IMMUNOLOGICAL METHODS 3633
24364 1                   BETA D GALACTOSIDASE//NONCOMPETITIVE IMMUNOASSAY//GELATIN PARTICLE AGGLUTINATION 314

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BETA D GALACTOSIDASE authKW 889874 11% 28% 33
2 NONCOMPETITIVE IMMUNOASSAY authKW 735415 4% 69% 11
3 GELATIN PARTICLE AGGLUTINATION authKW 691524 3% 89% 8
4 PHAGE ANTI IMMUNOCOMPLEX ASSAY authKW 388983 1% 100% 4
5 ANTI HIV 1 IGG authKW 291738 1% 100% 3
6 ANTITHYROGLOBULIN IGG authKW 291738 1% 100% 3
7 QUENCHBODY authKW 218802 1% 75% 3
8 P17 authKW 201958 3% 23% 9
9 ANTI METATYPE ANTIBODY authKW 194492 1% 100% 2
10 ANTIBODY IGG authKW 194492 1% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Medical Laboratory Technology 9373 29% 0% 90
2 Chemistry, Analytical 1579 31% 0% 97
3 Biochemical Research Methods 874 18% 0% 57
4 Biochemistry & Molecular Biology 143 21% 0% 67
5 Immunology 106 11% 0% 33
6 Medicine, Legal 90 2% 0% 6
7 Biotechnology & Applied Microbiology 37 6% 0% 19
8 Biophysics 17 4% 0% 12
9 Food Science & Technology 13 4% 0% 11
10 Microbiology 12 4% 0% 13

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 KANONIJI 194492 1% 100% 2
2 KEY STATE BIOREACTOR ENGN 194492 1% 100% 2
3 LIFESCI RD 129660 1% 67% 2
4 BAT PHYSIOPATHOL CLIN UNITA GASTROENTEROL 97246 0% 100% 1
5 CHU SHERBROOKE PHYSIOL PHARMACOL 97246 0% 100% 1
6 CTE NANOBIO INTEGRAT 97246 0% 100% 1
7 DEP MED GENOME SCI 97246 0% 100% 1
8 DSISSSBSSLB 97246 0% 100% 1
9 DSV ETUD RADIOIMMUNOL 97246 0% 100% 1
10 ETUD RECH IMMUNOANALYSE 97246 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF CLINICAL LABORATORY ANALYSIS 133408 17% 3% 53
2 ANALYTICAL LETTERS PART B-CLINICAL AND BIOCHEMICAL ANALYSIS 39672 4% 3% 13
3 ANALYTICAL LETTERS 5825 6% 0% 20
4 JOURNAL OF IMMUNOLOGICAL METHODS 3249 6% 0% 18
5 ANALYTICAL CHEMISTRY 2102 9% 0% 28
6 JOURNAL OF IMMUNOASSAY 2093 1% 1% 3
7 NATURAL TOXINS 1766 0% 2% 1
8 JOURNAL OF BIOCHEMISTRY 1082 4% 0% 11
9 CLINICA CHIMICA ACTA 1054 4% 0% 11
10 CLINICAL CHEMISTRY 812 3% 0% 10

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 BETA D GALACTOSIDASE 889874 11% 28% 33 Search BETA+D+GALACTOSIDASE Search BETA+D+GALACTOSIDASE
2 NONCOMPETITIVE IMMUNOASSAY 735415 4% 69% 11 Search NONCOMPETITIVE+IMMUNOASSAY Search NONCOMPETITIVE+IMMUNOASSAY
3 GELATIN PARTICLE AGGLUTINATION 691524 3% 89% 8 Search GELATIN+PARTICLE+AGGLUTINATION Search GELATIN+PARTICLE+AGGLUTINATION
4 PHAGE ANTI IMMUNOCOMPLEX ASSAY 388983 1% 100% 4 Search PHAGE+ANTI+IMMUNOCOMPLEX+ASSAY Search PHAGE+ANTI+IMMUNOCOMPLEX+ASSAY
5 ANTI HIV 1 IGG 291738 1% 100% 3 Search ANTI+HIV+1+IGG Search ANTI+HIV+1+IGG
6 ANTITHYROGLOBULIN IGG 291738 1% 100% 3 Search ANTITHYROGLOBULIN+IGG Search ANTITHYROGLOBULIN+IGG
7 QUENCHBODY 218802 1% 75% 3 Search QUENCHBODY Search QUENCHBODY
8 P17 201958 3% 23% 9 Search P17 Search P17
9 ANTI METATYPE ANTIBODY 194492 1% 100% 2 Search ANTI+METATYPE+ANTIBODY Search ANTI+METATYPE+ANTIBODY
10 ANTIBODY IGG 194492 1% 100% 2 Search ANTIBODY+IGG Search ANTIBODY+IGG

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 KOBAYASHI, N , GOTO, J , (2001) NONCOMPETITIVE IMMUNOASSAYS FOR SMALL MOLECULES WITH HIGH SENSITIVITY AND SPECIFICITY.ADVANCES IN CLINICAL CHEMISTRY, VOL 36. VOL. 36. ISSUE . P. 139 -170 29 58% 20
2 ISHIKAWA, E , ISHIKAWA, S , HASHIDA, S , HASHINAKA, K , (1998) POTENTIAL OF THE IMMUNE COMPLEX TRANSFER ENZYME IMMUNOASSAY FOR ANTIGENS AND ANTIBODIES TO IMPROVE THE SENSITIVITY AND ITS LIMITATIONS.JOURNAL OF CLINICAL LABORATORY ANALYSIS. VOL. 12. ISSUE 3. P. 154-161 18 100% 4
3 HASHIDA, S , ISHIKAWA, S , HASHINAKA, K , NISHIKATA, I , OKA, S , ISHIKAWA, E , (2000) EARLIER DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 P24 ANTIGEN AND IMMUNOGLOBULIN G AND M ANTIBODIES TO P17 ANTIGEN IN SEROCONVERSION SERUM PANELS BY IMMUNE COMPLEX TRANSFER ENZYME IMMUNOASSAYS.CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY. VOL. 7. ISSUE 6. P. 872-881 21 68% 7
4 ISHIKAWA, S , HASHIDA, S , HASHINAKA, K , ADACHI, A , OKA, S , ISHIKAWA, E , (1998) RAPID FORMATION OF THE IMMUNE COMPLEXES ON SOLID PHASE IN THE IMMUNE COMPLEX TRANSFER ENZYME IMMUNOASSAYS FOR HIV-1 P24 ANTIGEN AND ANTIBODY IGGS TO HIV-1.JOURNAL OF CLINICAL LABORATORY ANALYSIS. VOL. 12. ISSUE 4. P. 227-237 15 100% 0
5 LI, P , DENG, SL , (2016) MIMETIC PEPTIDE AND SPECIAL ANTIBODY: PROMISING AGENTS FOR OPTIMIZING HAPTEN-ANALYZING SYSTEMS.ANALYTICAL METHODS. VOL. 8. ISSUE 12. P. 2554 -2560 23 36% 0
6 ISHIKAWA, E , HASHIDA, S , KOHNO, T , (1991) DEVELOPMENT OF ULTRASENSITIVE ENZYME-IMMUNOASSAY REVIEWED WITH EMPHASIS ON FACTORS WHICH LIMIT THE SENSITIVITY.MOLECULAR AND CELLULAR PROBES. VOL. 5. ISSUE 2. P. 81-95 23 77% 12
7 HASHIDA, S , ISHIKAWA, S , HASHINAKA, K , NISHIKATA, I , OKA, S , SHIMADA, K , SAITO, A , TAKAMIZAWA, A , SHINAGAWA, H , ISHIKAWA, E , (1998) OPTIMAL CONDITIONS OF IMMUNE COMPLEX TRANSFER ENZYME IMMUNOASSAYS FOR ANTIBODY IGGS TO HIV-1 USING RECOMBINANT P17, P24, AND REVERSE TRANSCRIPTASE AS ANTIGENS.JOURNAL OF CLINICAL LABORATORY ANALYSIS. VOL. 12. ISSUE 2. P. 98 -107 15 88% 1
8 HASHIDA, S , ISHIKAWA, S , NISHIKATA, I , HASHINAKA, K , OKA, S , ISHIKAWA, E , (1998) IMMUNE COMPLEX TRANSFER ENZYME IMMUNOASSAY FOR ANTIBODY IGM TO HIV-1 P17 ANTIGEN.JOURNAL OF CLINICAL LABORATORY ANALYSIS. VOL. 12. ISSUE 6. P. 329-336 14 93% 1
9 HASHINAKA, K , HASHIDA, S , NISHIKATA, I , ADACHI, A , OKA, S , ISHIKAWA, E , (2000) RECOMBINANT P51 AS ANTIGEN IN AN IMMUNE COMPLEX TRANSFER ENZYME IMMUNOASSAY OF IMMUNOGLOBULIN G ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1.CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY. VOL. 7. ISSUE 6. P. 967-976 17 71% 0
10 VOLLAND, H , PRADELLES, P , TARAN, F , BUSCARLET, L , CREMINON, C , (2004) RECENT DEVELOPMENTS FOR SPIE-IA, A NEW SANDWICH IMMUNOASSAY FORMAT FOR VERY SMALL MOLECULES.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 34. ISSUE 4. P. 737-752 21 50% 4

Classes with closest relation at Level 1


Rank Class id link
1 37475 ANTIBODY VARIABLE REGION//TRANSGENE SELECTION//COMMUNICATION DISTANCE
2 34945 HGP 30//MATRIX PROTEIN P17//HIV 1 MATRIX PROTEIN P17
3 16914 ANTIGEN HETEROLOGOUS//TESTOSTERONE 3 O CARBOXYMETHYLOXIME//15 ALPHA HYDROXYESTROGEN
4 8251 CANONICAL STRUCTURES//ANTIBODY MODELING//HUMANIZATION
5 36182 CELLULAR SIPPING//HORMONE STABILITY//244250 BATH RD
6 22389 DISCIPLINE MED VIROL//HIV1 GP160//NEURAMIDE
7 24974 PS TAG//1 FLUORO 2 NITRO 4 AZIDOBENZENE//AFFINITY PEPTIDE TAG
8 24154 IMMUNO PCR//PROXIMITY LIGATION ASSAY//LEHRSTUHL BIOL CHEM MIKROSTRUKTURTECH
9 16797 EUROPIUM CHELATE//BIOPHYS MEDICITY//TIME GATED LUMINESCENCE
10 5103 IMMUNOASSAY//INTE O BIOINGN//HAPTEN

Go to start page